Related Experiment Video
Updated: Jul 15, 2026

07:27
Recurrent Herpetic Stromal Keratitis in Mice, a Model for Studying Human HSK
Published on: December 18, 2012
11.9K
Rabbit Hemorrhagic Disease Virus 2 Experimental Infection in Snowshoe Hares (Lepus americanus)
Angela M Bosco-Lauth1, Stephanie M Porter2, Rachel M Maison1
1Department of Biomedical Sciences, 1683 Campus Delivery, Colorado State University, Fort Collins, Colorado 80523, USA.
Journal of Wildlife Diseases
|May 15, 2025
Summary
Snowshoe hares experimentally infected with Rabbit Hemorrhagic Disease Virus 2 (RHDV2) showed resistance to lethal disease. While infected and shedding virus, these lagomorphs demonstrated resilience, suggesting a lower clinical impact compared to other species.
Area of Science:
- Veterinary Virology
- Wildlife Disease Ecology
- Lagomorph Pathology
Background:
- Rabbit Hemorrhagic Disease Virus 2 (RHDV2) is a highly contagious and lethal virus affecting lagomorphs.
- RHDV2 outbreaks have been documented globally, with recent establishment in the US.
Purpose of the Study:
- To investigate the susceptibility and response of snowshoe hares (Lepus americanus) to RHDV2 infection.
- To assess viral shedding and seroconversion in experimentally infected snowshoe hares.
Main Methods:
- Six snowshoe hares were orally inoculated with infectious RHDV2.
- Animals were monitored for clinical signs, viral shedding (PCR), and serological response for 14 days.
- Histopathological examination of liver tissues was performed postmortem.
Main Results:
- No snowshoe hares died during the 14-day experimental period.
- Histopathology revealed evidence of hepatic injury recovery.
- RHDV2 was detected in liver and fecal samples, confirming infection and shedding.
- A majority of hares (5/6) seroconverted by the study's end.
Conclusions:
- Snowshoe hares are susceptible to RHDV2 infection and capable of viral shedding.
- These lagomorphs exhibit relative resistance to severe clinical disease and mortality from RHDV2.
- Findings suggest a potential role for snowshoe hares in RHDV2 epidemiology, albeit with a lower clinical impact.

